Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19

Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
Drug Metabolism and Disposition November 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279
Carole Giraud
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnès Tran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Rey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Vincent
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Marc Tréluyer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gérard Pons
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 11 1279-1286
DOI 
https://doi.org/10.1124/dmd.32.11.1279

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received January 5, 2004
  • Accepted July 30, 2004
  • Published online October 13, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Carole Giraud,
  2. Agnès Tran,
  3. Elisabeth Rey,
  4. Jean Vincent,
  5. Jean-Marc Tréluyer and
  6. Gérard Pons
  1. Pharmacologie, Groupe Hospitalier Cochin-Saint-Vincent de Paul, Assistance Publique-Hôpitaux de Paris, Université René Descartes (C.G., E.R., J.M.T., G.P.); Ecole Pratique des Hautes Etudes (A.T.), Paris; and Laboratoires Biocodex, Montrouge (J.Y.), France
  1. Address correspondence to:
    Agnès Tran, Ecole Pratique des Hautes Etudes, Pharmacologie, Hôpital Saint Vincent de Paul, 82 avenue Denfert-Rochereau, 75674 Paris cedex 14, France. E-mail: agnes.tran{at}ephe.sorbonne.fr
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to September 2023

AbstractFullPdf
Aug 201763910
Sep 201721926
Oct 201774219
Nov 201769823
Dec 20172198
Jan 20183248
Feb 201831913
Mar 20185168
Apr 201845921
May 2018416412
Jun 201841038
Jul 201825213
Aug 2018102318
Sep 20185408
Oct 20181708
Nov 201826315
Dec 201871216
Jan 20197410
Feb 20197088
Mar 20192322
Apr 20193231
May 20191822
Jun 20193617
Jul 20192554
Aug 20192812
Oct 20193512
Nov 20193222
Dec 20194401
Jan 20203623
Feb 20203846
Mar 20204513
May 20203351
Jun 20202030
Jul 20203322
Aug 20202411
Sep 20202330
Oct 20203933
Nov 20202900
Dec 20203310
Jan 20212643
Feb 20212730
Mar 20214311
Apr 20213354
May 20212910
Jun 20212240
Jul 20212121
Aug 20213081
Sep 20216193
Oct 20213741
Nov 20213210
Dec 20213320
Jan 20223421
Feb 20223642
Mar 20223110
Apr 20223561
May 20222733
Jun 20223511
Jul 20222620
Aug 20223520
Sep 20223353
Oct 20224042
Nov 20223935
Dec 20222054
Jan 20235551
Feb 20233532
Mar 20236150
Apr 20232762
May 20232361
Jun 20231582
Jul 20233354
Aug 20232131
Sep 20231634

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (11)
Drug Metabolism and Disposition
Vol. 32, Issue 11
1 Nov 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19

Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
Drug Metabolism and Disposition November 1, 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19

Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer and Gérard Pons
Drug Metabolism and Disposition November 1, 2004, 32 (11) 1279-1286; DOI: https://doi.org/10.1124/dmd.32.11.1279
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Ontogeny of CPPGL
  • Expression of AKR and SDR Isoforms in the Human Intestine
  • Is Protein-Mediated Uptake Effect a Real Phenomenon?
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics